Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nacuity Pharmaceuticals, Inc.

Clinical trials sponsored by Nacuity Pharmaceuticals, Inc., explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 1

New pill aims to slow vision loss in rare usher syndrome

Disease control Ongoing

This study tests whether an experimental tablet called NPI-001 can safely slow or stop vision loss in people with Usher syndrome, a rare genetic condition that causes blindness and hearing loss. About 49 adults will take either the drug or a placebo for 24 months. The main goal i…

Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 17, 2026 14:53 UTC